دورية أكاديمية

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.

التفاصيل البيبلوغرافية
العنوان: Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.
المؤلفون: Vignozzi, Linda, Cellai, Ilaria, Santi, Raffaella, Lombardelli, Letizia, Morelli, Annamaria, Comeglio, Paolo, Filippi, Sandra, Logiodice, Federica, Carini, Marco, Nesi, Gabriella, Gacci, Mauro, Piccinni, Marie-Pierre, Adorini, Luciano, Maggi, Mario
المصدر: Journal of Endocrinology; Jul2012, Vol. 214 Issue 1, p31-43, 13p
مصطلحات موضوعية: BENIGN prostatic hyperplasia, ANTI-inflammatory agents, ANDROGEN receptors, HYPOGONADISM, THERAPEUTIC use of testosterone, PROSTATECTOMY
مستخلص: Progression of benign prostatic hyperplasia (BPH) involves chronic inflammation and immune dysregulation. Preclinical studies have demonstrated that prostate inflammation and tissue remodeling are exacerbated by hypogonadism and prevented by testosterone supplementation. We now investigated whether, in humans, hypogonadism was associated with more severe BPH inflammation and the in vitro effect of the selective androgen receptor agonist dihydrotestosterone (DHT) on cultures of stromal cells derived from BPH patients (hBPH). Histological analysis of inflammatory infiltrates in prostatectomy specimens from a cohort of BPH patients and correlation with serum testosterone level was performed. Even after adjusting for confounding factors, hypogonadism was associated with a fivefold increased risk of intraprostatic inflammation, which was also more severe than that observed in eugonadal BPH patients. Triggering hBPH cells by inflammatory stimuli (tumor necrosis factor α, lipopolysaccharide, or CD4+T cells) induced abundant secretion of inflammatory/growth factors (interleukin 6 (IL6), IL8, and basic fibroblast growth factor (bFGF)). Co-culture of CD4+T cells with hBPH cells induced secretion of Th1 inducer (IL12), Th1-recruiting chemokine (interferon γ inducible protein 10, IP10), and Th2 (IL9)- and Th17 (IL17)-specific cytokines. Pretreatment with DHT inhibited NF-kB activation and suppressed secretion of several inflammatory/growth factors, with the most pronounced effects on IL8, IL6, and bFGF. Reduced inflammatory cytokine production by testosterone cells, an increase in IL10, and a significant reduction of testosterone cells proliferation suggested that DHT exerted a broad antiinflammatory effect on testosterone cells. In conclusion, our data demonstrate that DHTexerts an immune regulatory role on human prostatic stromal cells, inhibiting their potential to actively induce and/or sustain autoimmune and inflammatory responses. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Endocrinology is the property of Bioscientifica and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00220795
DOI:10.1530/JOE-12-0142